euro adhoc: november AG / Personnel / New executive board will be assigned on 01.04.2007 Supervisory board appoints Dr. Müller as chief executive officer, Mr. Schüren and Ms. Dickert agreed to resign
-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------
C.E.O. Interviews
28.03.2007
Erlangen, 28 March 2007. On today’s scheduled supervisory board-meeting of november AG, a biotech development and investment holding in Erlangen, Germany (ISIN DE0006762909) Mr Reinhard Schüren as CEO and Ms. Astrid Dickert as CFO, announced that they have amicably agreed upon their resignation with the supervisory board effective 31st March 2007. The supervisory board unanimously appointed Dr. Claus Müller effective 01.04.2007 as new CEO until 31.03.2010. Dr. Müller will also be responsible for the new executive department "Sales & Marketing". As further members of the company’s executive board, the supervisory board appointed Mr. Jürgen Haegele as CFO until 30.09.2007 and Prof. Dr. Dr. Hans Alois Dresel (research & development) until 31.03.2010, both effective 01.04.2007.
end of announcement euro adhoc 28.03.2007 14:07:47 --------------------------------------------------------------------------------
ots Originaltext: november AG Im Internet recherchierbar: http://www.presseportal.de
Further inquiry note: Marcus Weichert Leitung PR/IR Telefon: +49(0)9131 75088 868 E-Mail: weichert@november.de
Branche: Biotechnology ISIN: DE0006762909 WKN: 676290 Index: CDAX, Technologie All Share, Prime All Share Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime standard Börse Berlin-Bremen / free trade Baden-Württembergische Wertpapierbörse / free trade Börse Düsseldorf / free trade Niedersächsische Börse zu Hannover / free trade Bayerische Börse / free trade
